Special News Update February 2022 This special news update shares a couple of upcoming opportunities in the hepatitis space. We encourage you to share these with your networks. Jump to: Community Advisory Group: Advocacy opportunity for people with lived experience of liver disease, cirrhosis and/or liver cancer Job opportunity: Research Assistant for IC3 trial The VH2022 committee have announced the opening of Late Breaker abstract submissions for the 13th Australasian Viral Hepatitis Conference Community Advisory Group: Advocacy opportunity for people with lived experience of liver disease, cirrhosis and/or liver cancer Help guide a national clinical trial aiming to improve the detection of cirrhosis and screening for liver cancer in primary care. Do you have lived experience of liver disease, cirrhosis and/or liver cancer? Or caring for someone who does? Would you like to help guide a national clinical trial aiming to improve the detection of cirrhosis and screening for liver cancer in primary care? The CCIP Team from WA Health Translation Network is looking for up to 8 members from all over Australia, who have a lived experience of liver disease, cirrhosis and/or liver cancer to join this Community Advisory Group. This plays an important role in providing advice on consumer relevant matters and to act as an advocate for this research study. What experience do applicants need? Lived experience of liver disease, cirrhosis and/or liver cancer, or caring for someone who does. An open mind and willingness to partner with CCIP to make this trial the highest-quality research it can be. Any non-medical skills that can help to improve the consumer relevance of our research or to communicate, network or advocate for this research. Find out more and apply Applications close: 3 March 2022 About CCIPThe Consumer and Community Involvement Program (CCI Program) is an activity of the Western Australian Health Translation Network (WAHTN). The CCI Program supports consumers, community members and researchers to work in partnership to make decisions about health research priorities, policy and practice with the aim of improving health outcomes and ensuring community involvement becomes standard practice. Job opportunity: Research Assistant for IC3 trial The University Of Melbourne is seeking applications to join a team of world leaders and passionate professionals in cancer research. Screening programs save lives, and this team are committed to determining the feasibility and effectiveness of early screening programs to enhance cancer survival rates in at risk individuals. If you are passionate about research and delivering better public health outcomes for at risk populations and want to work in a collaborative and supportive team, this role may be for you.Role type: Full time / Fixed-term for 24 monthsFaculty: Faculty of Medicine, Dentistry and Health Sciences More info and apply The VH2022 committee have announced the opening of Late Breaker abstract submissions for the 13th Australasian Viral Hepatitis Conference. If you missed the chance to submit your abstract earlier this year, we encourage you to take advantage of the Late Breaker opportunity to showcase your work as part of the program for the leading multidisciplinary viral hepatitis conference in Australasia. The committee is calling for Research Based Abstracts and Practice Based & Multimedia Abstracts for the below disciplines. Late Breaker Abstract Submission Deadline 11.59pm AEST Sunday 27 March 2022 *There will be no further extensions to this submission deadline* Abstract Submission Manage Cookie Preferences